ANGIODYNAMICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.76 USD | +1.41% |
|
+1.95% | -26.53% |
Presentation Operator MessageOperator (Operator)Good day, and welcome to the AngioDynamics 201...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Calendar
2024-07-09
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.76
USD
Average target price
13.5
USD
Spread / Average Target
+134.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -26.53% | 231M | |
| -4.72% | 182B | |
| -2.83% | 103B | |
| -5.01% | 66.94B | |
| +15.53% | 46.73B | |
| -8.53% | 45.14B | |
| +5.82% | 41.57B | |
| +17.67% | 30.48B | |
| +14.00% | 24.26B | |
| -8.08% | 23.58B |
- Stock Market
- Equities
- ANGO Stock
- News AngioDynamics, Inc.
- Transcript : AngioDynamics Inc., Q4 2016 Earnings Call, Jul 13, 2016
